enGene Therapeutics officer Jason Duncan files initial beneficial ownership statement
ENGN•Chief Legal and Administrative Officer Jason Duncan filed an initial beneficial ownership statement dated Nov. 13, 2026.
1. Ownership filing
enGene Therapeutics Chief Legal and Administrative Officer Jason Duncan filed an initial statement of beneficial ownership dated Nov. 13, 2026.
